Mutant mice exhibited accelerated development of lesions associated with prostate cancer progression, implicating selenoproteins in cancer risk and raising the possibility that Se prevents cancer by modulating the levels of stress-related selenoproteins.First demonstration that selenoproteins reduce prostate cancer incidence. Here, SELENOS is linked to prostate carcinoma.